Rosario L. Bianco

Avellino, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Do quadruplet induction regimens for myeloma necessitate new mobilization strategies to obtain optimal CD34+ cell yields?

Do quadruplet induction regimens for myeloma necessitate new mobilization strategies to obtain optimal CD34+ cell yields?

Journal: Leukemia & lymphoma

Published: March 17, 2026

Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.

Efficacy of Momelotinib in Myelofibrosis Patients: Results From a Multicenter Study.

Journal: European journal of haematology

Published: July 14, 2025

An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.

An Italian real-world multicenter study of patients with refractory/relapsed functional high-risk multiple myeloma patients treated with second-line therapies.

Journal: Annals of hematology

Published: April 18, 2025

Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.

Comparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data.

Journal: Haematologica

Published: January 07, 2025

Influence of stem and bud auxin levels on bud release and flower meristem formation in Citrus.

Influence of stem and bud auxin levels on bud release and flower meristem formation in Citrus.

Journal: Plant science : an international journal of experimental plant biology

Published: September 28, 2024

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.

Isatuximab, pomalidomide, and dexamethasone as salvage therapy for patients with multiple myeloma: the Italian, multicenter, retrospective clinical experience with 270 cases outside of controlled clinical trials.

Journal: Haematologica

Published: September 15, 2024

Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.

Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.

Journal: HemaSphere

Published: July 31, 2024

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Clinical Efficacy of Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Journal: European journal of haematology

Published: July 23, 2024

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience.

Journal: Targeted oncology

Published: September 08, 2023

Evans Syndrome Presenting as an Atypical Complication of SARS-CoV-2 Vaccination.

Evans Syndrome Presenting as an Atypical Complication of SARS-CoV-2 Vaccination.

Journal: Cureus

Published: July 05, 2022

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.

Real-world evidence of cytomegalovirus reactivation in non-Hodgkin lymphomas treated with bendamustine-containing regimens.

Journal: Open medicine (Warsaw, Poland)

Published: December 27, 2020

Mesenchymal Stem Cells from the Wharton's Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential.

Mesenchymal Stem Cells from the Wharton's Jelly of the Human Umbilical Cord: Biological Properties and Therapeutic Potential.

Journal: International journal of stem cells

Published: April 12, 2018

Showing 1-12 of 12

Last Updated: 09/26/2026